Allosteric regulation
- Control of glutamate release by complexes of adenosine and cannabinoid receptors (24 Sep 2024)
- The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease (02 Sep 2024)
- Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor (02 Sep 2024)
- Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism (02 Sep 2024)
- Determination of the Cannabinoid CB1 Receptor’s Positive Allosteric Modulator Binding Site through Mutagenesis Studies (02 Sep 2024)
- A collection of cannabinoid-related negative findings from autaptic hippocampal neurons (30 Aug 2024)
- New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 (28 Aug 2024)
- Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
- The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors (21 Aug 2024)
- Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries (21 Aug 2024)
- Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products (20 Aug 2024)
- Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity (20 Aug 2024)
- Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study (19 Aug 2024)
- Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation (19 Aug 2024)
- Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (18 Aug 2024)
- Cannabinoid receptor type-1: breaking the dogmas (18 Aug 2024)
- Cannabinoids and COVID-19 (25 Jul 2022)